Clinical Trial Update: Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing pharmacodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 versus standard Insulin Aspart in adults with Type 1 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Biphasic Insulin Aspart 30, 50, 70 (biphasic insulin aspart formulations (30/50/70))
• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED